OKYO Pharma Stock Based Compensation Over Time

OKYO Stock  USD 1.01  0.03  2.88%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out OKYO Pharma Performance and OKYO Pharma Correlation.
  
As of the 5th of December 2024, Stock Based Compensation is likely to grow to about 1.2 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.57)
Return On Assets
(2.92)
Return On Equity
(29.69)
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Stock Based Compensation Analysis

Compare OKYO Pharma and related stocks such as Bionomics Limited, Candel Therapeutics, and Anebulo Pharmaceuticals Stock Based Compensation Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
CADL400 K400 K400 K400 K400 K400 K400 K400 K400 K400 K2.1 MM2.3 M3.1 M2.4 M
ANEB199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K480.7 K884.7 K758.9 K639.2 K
CINGW0.00.00.00.00.00.00.00.00.00.00.012.8 M800.8 K812.7 K772 K
UNCY24 K24 K24 K24 K24 K24 K24 K24 K24 K24 K232 K966 KM1.8 M887.9 K
QNRX0.00.00.00.00.00.00.00.00.00.00.00.0764 K1.1 M681.5 K
CDIO589.3 K589.3 K589.3 K589.3 K589.3 K589.3 K589.3 K589.3 K589.3 K589.3 K589.3 K60 KK1.3 M1.3 M
VRAX0.00.00.00.00.00.00.00.00.00.00.0290.4 K1.7 MM835.2 K
SNTI205 K205 K205 K205 K205 K205 K205 K205 K205 K205 K272 K2.3 M16.4 M9.7 M6.3 M
CVKD710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K710.4 K639.3 K568.3 K
FHTX732 K732 K732 K732 K732 K732 K732 K732 K732 K1.7 MM8.4 M14.3 M16.2 M8.1 M
CMND147.3 K147.3 K147.3 K147.3 K147.3 K147.3 K147.3 K147.3 K0.00.0500.2 K887.3 K264.9 K304.7 K330 K
COEP0.00.00.00.00.00.00.00.00.00.00.01.9 M122.4 K477.5 K499.5 K

OKYO Pharma and related stocks such as Bionomics Limited, Candel Therapeutics, and Anebulo Pharmaceuticals Stock Based Compensation description

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

My Equities

My Current Equities and Potential Positions

OKYO Pharma Ltd
OKYO
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationUnited Kingdom
ExchangeNASDAQ Exchange
USD 1.01
When determining whether OKYO Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OKYO Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Okyo Pharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Okyo Pharma Ltd Stock:
Check out OKYO Pharma Performance and OKYO Pharma Correlation.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
OKYO Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of OKYO Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of OKYO Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...